For many decades, the best clinicians could offer patients with atopic dermatitis (AD) was foundational treatment with mild cleansers, moisturizers, and trials of topical corticosteroids and topical calcineurin inhibitors. Systemic immunosuppressants offer some relief, but at the expense of side effects. While foundational therapies are still an integral part of managing AD, there has been an explosion of recent research and clinical experience with agents that target cytokine pathways, including dupilumab, which is now FDA-approved for adults, adolescents, and younger pediatric patients with moderate to severe AD. These agents can provide significantly enhanced disease management and improved quality of life.
Clinical review and case study
After completing this activity, participants should be better able to:
- Apply recommended proactive approaches to the identification and management of AD
- Identify treatment strategies for AD that include use of novel therapies as appropriate
- Implement strategies for long-term management of AD, with a focus on patient-centered management
NPs and PAs
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit
CNE course advisor: Mary Knudtson, DNSc, NP, FAAN, University of California, Irvine, Irvine, California
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until October 4, 2021. PAs should only claim credit commensurate with the extent of their participation.
PA course advisor: Lawrence Herman, MPA, PA-C, Palantir Healthcare LLC, Boiling Springs, South Carolina
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity was developed from a series of programs cosupported by educational grants from AbbVie Inc.; Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC; Genentech, a member of the Roche Group; Novo Nordisk Inc.; Sanofi Genzyme; and Sanofi Genzyme and Regeneron Pharmaceuticals.
This activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange are required to disclose to the audience any relevant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Sidbury: advisory board: Pfizer; consultant: Micreos; principal investigator: Galderma, Regeneron.
Mr Herman: consultant/speakers bureau: Novo Nordisk.
None of the members of the planning committee or PCE staff have any relevant relationships to disclose, except Mr Herman as noted above.
Participants wishing to earn CE/CME credit must:
- Read the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hours.
Release date: October 5, 2020
Expiration date: October 4, 2021
© 2020 Practicing Clinicians Exchange. All Rights Reserved. 97220CPCE-7A